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Abstract
Background: A better description of the clinical and laboratory manifestations of fatal patients with dengue hemorrhagic
fever (DHF) is important in alerting clinicians of severe dengue and improving management.
Methods and Findings: Of 309 adults with DHF, 10 fatal patients and 299 survivors (controls) were retrospectively analyzed.
Regarding causes of fatality, massive gastrointestinal (GI) bleeding was found in 4 patients, dengue shock syndrome (DSS)
alone in 2; DSS/subarachnoid hemorrhage, Klebsiella pneumoniae meningitis/bacteremia, ventilator associated pneumonia,
and massive GI bleeding/Enterococcus faecalis bacteremia each in one. Fatal patients were found to have significantly higher
frequencies of early altered consciousness (#24 h after hospitalization), hypothermia, GI bleeding/massive GI bleeding, DSS,
concurrent bacteremia with/without shock, pulmonary edema, renal/hepatic failure, and subarachnoid hemorrhage. Among
those experienced early altered consciousness, massive GI bleeding alone/with uremia/with E. faecalis bacteremia, and K.
pneumoniae meningitis/bacteremia were each found in one patient. Significantly higher proportion of bandemia from initial
(arrival) laboratory data in fatal patients as compared to controls, and higher proportion of pre-fatal leukocytosis and lower
pre-fatal platelet count as compared to initial laboratory data of fatal patients were found. Massive GI bleeding (33.3%) and
bacteremia (25%) were the major causes of pre-fatal leukocytosis in the deceased patients; 33.3% of the patients with pre-
fatal profound thrombocytopenia (,20000/mL), and 50% of the patients with pre-fatal prothrombin time (PT) prolongation
experienced massive GI bleeding.
Conclusions: Our report highlights causes of fatality other than DSS in patients with severe dengue, and suggested
hypothermia, leukocytosis and bandemia may be warning signs of severe dengue. Clinicians should be alert to the potential
development of massive GI bleeding, particularly in patients with early altered consciousness, profound thrombocytopenia,
prolonged PT and/or leukocytosis. Antibiotic(s) should be empirically used for patients at risk for bacteremia until it is
proven otherwise, especially in those with early altered consciousness and leukocytosis.
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Introduction
Dengue is the most prevalent mosquito-borne viral infection in
the world [1]. Clinically, dengue ranges from asymptomatic,
nonspecific febrile illness, classic dengue, to dengue hemorrhagic
fever/dengue shock syndrome (DHF/DSS) [1]. Fatality rate and
causes of fatality in dengue-affected patients greatly varied from
one report to another [1–13]. While DSS was the major cause of
fatality in patients with dengue illness reported in some series [1–
13], causes other than DSS were predominantly responsible for
fatality reported in others [2,10,12–14]. However, only a small
number of dengue-attributed mortality cases were included for
analysis in each of these series [2,8,10–12]. A better description of
the clinical and laboratory presentations of cases with fatal
outcome may lead clinicians to an earlier recognition of the
warning signs of severe dengue resulting in timely and improved
management. To achieve this, the importance of continuous
analysis of relevant findings in fatal patients from dengue-affected
populations cannot be overemphasized.
Among the major dengue epidemics in Taiwan over the past 3
decades, a large dengue outbreak caused by DENV-1 occurred in
1987–1988 in southern Taiwan, followed by another one caused
by DENV-2 in 2002 in the same geographic area [15]. During the
2002 dengue epidemic in southern Taiwan, more than 5000
dengue cases were reported, and most of them were DHF that
developed in adults [15,16]; of note, dengue-related fatality was
found in 10 adults admitted at Kaohsiung Chang Gung Memorial
Hospital (KSCGMH), a 2500-bed facility serving as a primary
care and tertiary referral center in this area. In this study, we
retrospectively compared the clinical and laboratory features of
dengue-affected adults who turned out to be fatal and who
survived, and analyzed the fatal dengue cases aiming at
www.plosntds.org 1 February 2012 | Volume 6 | Issue 2 | e1532understanding the causes of mortality and clarifying the clinical
and laboratory evolutions preceding mortality.
Materials and Methods
Ethics statement
The data in this work were analyzed anonymously, and the
study was conducted with a waiver of patient consent approved
by the Institutional Review Board of KSCGMH (Document
No. 99-2671B).
Patients and definitions
Patients with the diagnosis of dengue admitted to KSCGMH
between June and December 2002 were potentially eligible for
inclusion in this retrospective study. All clinically diagnosed
dengue cases were serologically confirmed by at least one of the
following criteria: (i) a positive reverse transcriptase-polymerase
chain reaction (RT-PCR), (ii) a positive enzyme-linked immuno-
sorbent assay for specific immunoglobulin M antibody for dengue
virus in the acute-phase serum, and (iii) at least fourfold increase in
dengue-specific hemagglutination inhibition titers in the convales-
cent serum when compared to that in acute-phase serum [17]. The
diagnosis of DHF was established based on the presence of fever,
hemorrhage, thrombocytopenia (,100610
9 cells/L) and clinical
evidence of plasma leak (i.e., presence of hemoconcentration,
pleural effusion, ascites and/or hypoalbuminemia) indicating
increased vascular permeability [17]. Hemoconcentration referred
to .20% increase in hematocrit calculated as: (maximum
hematocrit - minimum hematocrit)6100/minimum hematocrit.
The severity of DHF in serologically confirmed dengue patients
was stratified based on the World Health Organization (WHO)
criteria. Grade I referred to a positive tourniquet test result being
the only hemorrhagic manifestation, while grade II referred to
spontaneous bleeding. Grade III referred to a circulatory failure
manifested by a rapid and weak pulse, as well as a narrowing pulse
pressure (x20 mmHg), whereas grade IV referred to a profound
shock, with an undetectable pulse or blood pressure [17]. Grades
III and IV of DHF were grouped as DSS [17].
All fatal DHF patients in this series resulted in dengue-related
mortality which referred to the death that occurred within three
weeks after hospitalization because of DHF. Hypothermia referred
to a temperature ,36uC detected at least twice from the ear drum
of a dengue-affected patient. Massive gastrointestinal (GI) bleeding
was defined as the passage of large amount of tarry or bloody stool
coupled with hemodynamic instability and/or rapid decrease in
hemoglobin level to x7.0 g/dL. Acute renal failure was defined as
a rapid increase in serum creatinine (Cr) level §0.5 mg/dL when
compared to that found at the patient’s hospital presentation.
Acute hepatic failure was defined as a raise in serum alanine
aminotransferase (ALT) level §400 U/L (reference value,
,40 U/L). Leukocytosis was defined as a peripheral white cell
count .12000/mL. Bandemia referred to the presence of band-
form granulocytes in the peripheral blood. Profound thrombocy-
topenia referred to a platelet count ,20000/mL. Prolongation of
prothrombin time (PT) was defined as a PT$3 seconds than a
control, and prolongation of activated partial thromboplastin time
(APTT) as an APTT $20% than a control. Concurrent
bacteremia was defined as a positive bacterial growth from blood
that was sampled for culture within 72 h after the patient was
hospitalized for dengue.
Demographic, clinical, laboratory and imaging information of
the included DHF patients were retrieved from the retrospective
review of their medical charts for analyses. Initial laboratory data
referred to data detected from the dengue-affected patients upon
their arrival at KSCGMH. Pre-fatal laboratory data were those
detected from the blood specimens of the fatal patients sampled
within the immediate 48 h before fatality.
Statistical analysis
The 309 DHF patients included for analyses were separated
into two groups: those who were fatal (fatal group, N=10) and
those survived (control group, N=299). The survived patients
were those with detailed information available. We compared the
demographic, clinical, imaging characteristics and initial labora-
tory data of the fatal patients and those of the controls, as well as
the pre-fatal laboratory data and the initial laboratory data of the
fatal patients. Mann-Whitney U test was used in comparison of
continuous variables, while the Fisher’s exact test was used to in
assessment of dichotomous variables. A 2-tailed P,0.05 was
considered statistically significant.
Results
Description of demographics and clinical manifestations
of fatal patients
A total of 714 adults with dengue illness were found at
KSCGMH during the study period, and among them, 10 (8 men
and 2 women; median age, 63.5 years [range, 33–78]) with DHF
(7 grade II DHF and 3 DSS) turned out to be fatal, accounting for
a dengue-related mortality rate of 1.3% (details are shown in
Table S1). Of these fatal patients, the time lapses between dengue
onset and hospital presentation ranged from 1 to 6 days (median, 2
days), between hospital presentation to fatality 2 to 18 days
(median, 4.5 days), and between dengue onset to fatality 4 to 21
days (median, 7.5 days). With the exception of patient 2 in whom
the dengue diagnostic test was carried out from the blood
specimen collected on the day 3 of his hospitalization, all patients
had their blood sampled for dengue diagnosis within 24 h after
admission. The median from dengue onset to the definitive
Author Summary
Fatality rate and causes of fatality in dengue-affected
patients greatly varied from one reported series to
another. A better understanding of the clinical and
laboratory manifestations of fatal patients with dengue
hemorrhagic fever (DHF) is important in alerting clinicians
of severe dengue and improving management. In a
retrospective analysis of 10 adults who died of and 299
survived (controls) DHF, dengue shock syndrome (DSS)
alone was found in only 20% of dengue-related death,
while intractable massive gastrointestinal (GI) bleeding
was found in 40%, and DSS with concurrent subarachnoid
hemorrhage, intractable massive GI bleeding with concur-
rent bacteremia, bacterial sepsis/meningitis, and sepsis
due to ventilator associated pneumonia each were found
in 10%. Early altered consciousness (developed #24 h
after hospitalization), GI bleeding/massive GI bleeding and
concurrent bacteremia were significantly found among the
deceased patients. Our data suggest that hypothermia,
leukocytosis and bandemia at hospital presentation may
be warning signs of severe dengue. Clinicians should be
alert to the potential development of massive GI bleeding,
particularly in patients with early altered consciousness,
profound thrombocytopenia, prothrombin time prolonga-
tion and/or leukocytosis. Antibiotic(s) should be empiri-
cally used for patients at risk for bacteremia until it is
proven otherwise, especially in those with early altered
consciousness and leukocytosis.
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DENV-2 in all fatal patients was confirmed by RT-PCR.
Manifestations indicating plasma leak in these fatal patients
included hemoconcentration (patients 2, 5–10), presence of pleural
effusion (patients 1, 3–6, 8 and 10) and hypoalbuminemia (patients
1, 2 and 4). Seven patients (patients 1–4, 6, 7 and 9) with grade II
DHF experienced shock resulting from bacterial sepsis (patients 1
and 4), concurrent bacterial sepsis and massive GI bleeding
(patient 9), and massive GI bleeding (patients 2, 3, 6, and 7). DSS
alone was found in 3 (patients 5, 8 and 10) patients. Shock,
regardless of cause, developed 1 to 16 days (median, 3 days) after
their hospitalizations, and 4 and 17 days (median, 6.5 days) after
dengue onset. Among the 3 DSS patients, DSS was recognized on
day 3 (patients 8 and 10) and day 6 (patient 5) of their
hospitalization, respectively. Patient 2 experienced 2 episodes of
massive GI bleeding with hypovolemic shock on day 8 and day 16
of his hospital stay, respectively. Patient 4 with an underlying lung
cancer suffered septic shock on day 15 of his hospitalization. The
demographic, clinical and laboratory information of the fatal
patients and controls is summarized in Tables 1 and 2.
A variety of clinical manifestations were found in each of these
10 fatal patients (Table 1). The leading ones, in decreasing order,
were fever (.38uC) (90%), GI bleeding (90%), pleural effusion
(70%), bone pain and cough (each 60%). The previously reported
early warning signs for severe dengue [11,17,18], namely,
persistent vomiting was found in 4 (40%) patients, and sustained
abdominal pain in 2 (20%). Pulmonary edema developed in 3
(patients 4, 5 and 8) patients; 2 of them with DSS experienced
acute pulmonary edema emerged on day 5 (patient 5) and day 6
(patients 8) after dengue onset, respectively, while the other one
(patient 4) with lung cancer and hypoalbuminemia (serum
albumin, 1.4 g/dL [normal range, 3.0–4.5 g/dL]) experienced
septic shock on day 15 of hospitalization (day 17 after dengue
onset) thus receiving fluid resuscitation, and pulmonary edema was
found on following day. Acute renal failure was found in all of 8
patients (patients 1, 2, 4–9) with data available, and acute hepatic
failure in 4 (patients 1, 6–8) (57.1%) of 7 patients with data
available. Concurrent bacteremia was noted in 3 (patients 1, 4 and
9) (37.5%) of 8 fatal patients from whom blood was sampled for
bacterial culture within 72 h after their hospitalization (Table S1).
Of these 3 bacteremic patients, one (patient 1) experienced
Klebsiella pneumoniae meningitis, while the other two experienced
primary K. pneumonia (patient 4) and Enterococcus faecalis bacteremia
(patient 9), respectively. Of a total of 9 patients (patients 2–10) with
GI bleeding, 4 (patients 3, 7, 9 and 10) (44.4%) developed GI
bleeding at their arrival; 5 (patients 2, 3, 6, 7 and 9) (55.5%)
experienced massive GI bleeding, and 3 (patients 3, 7 and 9)
(33.3%) developed massive GI bleeding within 24 h after
admission. Among the 5 patients with massive GI bleeding, E.
faecalis bacteremia was found in one (patient 9); active bleeding was
endoscopically found in another (patient 3) with a gastric ulcer,
and in the other (patient 7) with hemorrhagic gastritis. Only
patients 3 and 7 received endoscopic examination. Among the 5
patients with massive GI bleeding, acute renal failure developed in
2 (patients 2 and 9), and concurrent acute renal and hepatic failure
in the other 2 (patients 6 and 7).
Of the 5 fatal patients with consciousness disturbance, 4
(patients 1, 2, 7 and 9) were found to developed altered
consciousness within 24 hours and one (patient 5) in the day 4
of his hospital stay. All of these 5 patients had blood sampled for
bacterial culture, and one of them (patient 1) had additional
cerebrospinal fluid sampled for bacterial culture. Among the 4
patients with early altered consciousness, massive GI bleeding
alone (patients 7), uremia and massive GI bleeding (patient 2), E.
faecalis bacteremia and massive GI bleeding (patient 9), and K.
pneumoniae meningitis and bacteremia (patient 1) each were found
in one. Hypernatremia (serum sodium .170 meq/L [normal
range, 134–148 meq/L]) was additionally found in patient 2 in
day 8 of his hospital stay. Altered consciousness abruptly
developed in patient 5 on day 4 of his hospitalization which
resulted from subarachnoid hemorrhage disclosed by a brain
computed tomography, and a cerebral angiographic study was
deferred because of his critical condition and acute renal failure in
particular; his blood culture for bacteria was negative, and
although hyperkalemia (serum potassium, 7.9 meq/L [normal
range, 3.6–5.0 meq/L]) was found on day 7, hemodialysis was not
carried out as it was hemodynamically unstable. Neither
hyperglycemia nor hypoglycemia was found in the 10 fatal
patients in this series. Hyponatremia was not found in our series.
Serum calcium level was not assayed in these fatal patients.
Hypothermia was noted in 2 (20%) patients (patients 6 and 9).
One patient (patient 9) with hypothermia detected at arrival
experienced concurrent primary E. faecalis bacteremia, while the
other (patient 6) experienced abrupt change in temperature with a
rapid switch from fever to hypothermia on day 4 of her hospital
stay, and her blood bacterial culture was negative.
All patients experienced respiratory failure that necessitated
mechanical ventilatory support. The mean time from patient’s
hospital presentation to starting mechanical ventilation was 3 days
(range, 1–6 days), and the root causes of respiratory failure included
massive GI bleeding (patients 3, 6, 7 and 9), sepsis (patient 1), DSS
(patients 8 and 10), subarachnoid hemorrhage (patient 5), persistent
drowsiness occurred within 24 h after hospitalization(patient 2) and
lung cancer with pleural effusion (patient 4).
Treatment for the 10 fatal patients
Intravenous fluid including 0.9% saline, Ringer’s lactate, and
5% dextrose in 0.9% saline was administered at infusion rates
ranging from 0.6 mL/Kg BW/h to 2.7 mL/Kg BW/h for the 10
fatal patients before development of shock and/or severe GI
hemorrhage. In addition, transfusion of platelets and/or other
blood component(s) (i.e., packed red blood cells and/or fresh
frozen plasma) was given for these fatal patients. Intravenous fluid
replacement and blood transfusion were detailed in Table S1.
Prior to shock development, intravenous fluid supplements with
0.9% saline for the 3 patients with DSS was 1.6 mL/Kg BW/h
(patients 5), 1.3 mL/Kg BW/h (patient 8) and 0.8 mL/Kg BW/h
(patient 10), respectively. Markedly elevated hemoglobin levels
were found in patients with DSS on the day shock developed.
Only platelet transfusion was given for these 3 patients before
development of DSS. Among the 5 (patients 2, 3, 6, 7 and 9)
patients with massive GI bleeding, intravenous fluid (0.9% saline
or Ringer’s lactate) supplement was infused at rates ranging from
1.4 mL/Kg BW/h to 2.5 mL/Kg BW/h before development of
hypovolemic shock, and 2 to 8 units of packed red blood cells were
transfused on the day the massive GI bleeding emerged (Table S1).
Because superimposing bacterial sepsis could not be excluded in
these critically ill patients, all of them received intravenous
antibiotic(s) within 72 h after admission. Upon hospitalization, the
3 patients (patients 1, 4 and 9) with concurrent bacteremia
received empirical antibiotic(s) (i.e., ceftriaxone for patient 1,
piperacillin and gentamicin for patient 4, and ceftriaxone and
penicillin for patient 9) to which the subsequently isolated bacteria
were susceptible in vitro.
Causes of fatalities
When it comes to causes of fatality in these10 fatal patients,
intractable massive GI bleeding with hypovolemic shock was
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*.
Variable
Fatal group
N=10
Control group
N=299 P
Demographic and clinical features
Median age, yrs (range) 63.5 (33–78) 55 (19–88) 0.219
Male 8 (80) 132 (44.1) 0.047
Underlying disease/condition
{
Diabetes mellitus 1 (10) 60 (20.1) 0.693
Hypertension 4 (40) 89 (29.8) 0.495
COPD 0 17 (5.7) .0.99
Previous stroke 1 (10) 22 (7.4) 0.544
Chronic kidney disease 2 (20) 12 (4) 0.070
Parkinsonism 1 (10) 2 (0.6) 0.094
Solid tumor
{ 1 (10) 3 (1) 0.124
Onset of dengue illness to arrival at hospital, median day (range) 2 (1–6) 3 (1–7) 0.055
Onset of dengue illness to shock, median day (range) 6.5 (4–17) - -
Onset of dengue illness to death, median day (range) 7.5 (4–21) - -
Admission to death, median day (range) 4.5 (2–18) - -
Hypovolemic shock due to massive GI bleeding 5
1(50) 2 (0.7) ,0.001
DSS 4 (40) 7 (2.3) ,0.001
Concurrent bacteremia, n/N (%) 3/8 (37.5) 3/77 (3.9) 0.010
With shock, n/N (%) 2/8
1" (25) 1
**/77 (1.3) 0.022
Without shock
{{, n/N (%) 1/8 (37.5) 2/77 (3.9) 0.259
Pleural effusion, n/N (%) 7
{{/10 (70) 81/212 (38.2) 0.054
Pulmonary edema, n/N (%) 3
11/10 (30) 6/212 (2.8) 0.005
Ascites, n/N (%) 0/3 (0) 64/160 (40) 0.280
Gallbladder swelling, n/N (%) 1/3 (33.3) 88/160 (55) 0.591
Acute renal failure, n/N (%) 8/8 (100) 6/298 (2) ,0.001
Acute hepatic failure, n/N (%) 4/7 (57.1) 5/114 (4.4) ,0.001
Symptom/sign
""
Fever (ear temperature .38uC) 9 (90) 283 (94.6) 0.437
Hypothermia (more than one ear temperature ,36uC) 2
*** (20) 0 0.001
Abdominal pain 2 (20) 154 (51.5) 0.059
Retro-orbital pain 3 (30) 36 (12) 0.119
Bone pain 6 (60) 174 (58.2) .0.99
Myalgia 4 (40) 44 (14.7) 0.053
Cough 6 (60) 105 (35.1) 0.176
Headache 3 (30) 135 (45.2) 0.521
Rashes 1 (10) 92 (30.8) 0.292
Vomiting 4 (40) 48 (16.1) 0.069
Gum bleeding 1 (10) 75 (25.1) 0.460
Petechiae 4 (40) 190 (63.5) 0.183
GI bleeding 9 (90) 48 (16) ,0.001
Massive GI bleeding 5 (50) 2 (0.7) ,0.001
Subarachnoid hemorrhage 1 (10) 0 0.032
Early altered consciousness (,24 h after hospitalization) 4
{{{ (40) 0 ,0.001
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(patients 8 and 10), while DSS with subarachnoid hemorrhage
(patient 5), K. pneumoniae bacteremia and meningitis with septic
shock (patient 1), sepsis due to mechanical ventilation associated
pneumonia (patient 4), as well as concurrent E. faecalis bacteremia
and intractable massive GI bleeding with shock (patient 9) each
(10%) were found in one patient. None of the fatal patients
underwent autopsy.
Pre-fatal laboratory features in the fatal patients
Pre-fatal leukocytosis was found in 6 (patients 4, 5, 6, and 8–10)
(66.7%) of the 9 patients (patients 1, 2, and 4–10) with data
available, and bandemia in 4 (patients 1, 2, 5 and 7) (66.7%) of the
6 patients (patients 1, 2 and 4–7) in whom the differential count of
peripheral white blood cells was available. Of the 6 patients with
development of pre-fatal leukocytosis, 2 (patients 4 and 10) had
leukopenia upon their arrival, 4 had their blood sampled for
bacterial culture and E. faecalis bacteremia (patient 9) was found in
one patient (25%), all experienced GI bleeding, and 2 (patients 6
and 9) (33.3%) developed massive GI bleeding. Prolongation of
pre-fatal PT was found in 6 (75%) (patients 2, 4–6, 8 and 9) of the
8 (patients 1, 2, 4–6, and 8–10) patients with data available. Of
note, all the 6 patients with pre-fatal PT prolongation developed
GI bleeding, and of them, 3 (50%) experienced massive GI
bleeding. Pre-fatal profound thrombocytopenia was found in 6
(60%) fatal patients (patients 1, 3, 5 and 8–10); of them, 5 (patients
3, 5 and 8–10) (83.3%) developed GI bleeding, and 2 (33.3%)
(patients 3 and 9) experienced massive GI bleeding. Pre-fatal
hyperkalemia was found in only 1 (patient 5) of the 6 (patients 2, 4,
5, 7–9) patients with data available.
*Data are number of patients (%), unless stated otherwise. DSS=Dengue shock syndrome; COPD=chronic obstructive pulmonary disease; GI=gastrointestinal;
n/N=no. of patients/no. of patients with data available.
{An individual patient might have more than one underlying disease/condition.
{One patient with lung cancer found in the fatal group; 2 patients with breast cancer and 1 with esophagus cancer found in the control group,.
1One patient with hypovolemia had a concurrent Enterococcus faecalis bacteremia.
"Blood culturewas available in 8 patients; one ofthem experienced Klebsiella pneumoniae meningitis and the other primary E. faecalis bacteremia, and shock was found in both.
**The patient had primary Rosemonas bacteremia.
{{Primary K. pneumoniae bacteremia was found in 1 patient the fatal group, and in 2 patients in the control group.
{{Three patients concurrently had pulmonary edema.
11One lung cancer patient developed pulmonary edema in day 16 of his hospitalization.
""An individual patient might have more than one symptom and/or sign.
***One originally febrile patient developed hypothermia during hospital stay.
{{{Three (75%) patients experienced massive GI bleeding.
doi:10.1371/journal.pntd.0001532.t001
Table 1. Cont.
Table 2. Laboratory information of the fatal and control groups*.
Variable
Initial laboratory data
(fatal group)
{ (A)
Initial laboratory data
(control group)
{ (B)
Pre-fatal laboratory data
(fatal group)
{ (C)
P
(A vs. B)
P
(C vs. A)
Leukopenia (WBC,3000/mL), n/N(%) 3/10 (30) 79/293 (27) 2/9 (22.2) 0.733 .0.99
Leukocytosis (WBC.12000/mL), n/N (%) 1/10 (10) 4/293 (1.4) 6/9 (66.7) 0.155 0.020
Bandemia
1, n/N (%) 3/8 (37.5) 5/277 (1.8) 4/6 (66.7) 0.001 0.592
Median platelet count (mL) (range) 35000 (3000–157000)
(N=10)
93000 (1000–303000)
(N=299)
17000 (9000–108000)
(N=10)
0.088 ,0.001
Platelet count ,20000/mL), n/N (%) 2/10 (20) 62/299 (20.7) 6/10 (60) .0.99 0.170
Median hemoglobin, g/dL (range) 11.7 (5.6–14.4) (N=10) 13.1 (7.5–19.9) (N=291) 8.9 (5.9–18.7) (N=10) 0.091 0.261
Median hematocrit, % (range) 33.8 (16.6–41) (N=10) 37.6 (16.7–57.2) (N=282) 27.6 (16.6–54.8) (N=10) 0.076 0.629
Prolongation of PT
", n/N (%) 1/4 (25) 3/147 (2) 6/8 (75) 0.103 0.222
Prolongation of APTT
**, n/N (%) 4/4 (100) 114/149 (76.5) 7/7 (100) 0.574 -
ALT .40 U/L (normal value ,40 U/L), n/N (%) 5/5 (100) 74/114 (64.9) 3/4 (75) 0.167 0.444
AST.40 U/L (normal value ,40 U/L), n/N (%) 6/7 (85.7) 125/161 (77.6) 5/5 (100) .0.99 .0.99
Albumin ,3.0 g/dL (normal value, 3.0–4.5 g/dL),
n/N (%)
0/3 (0) 6/46 (13) 3/4 (75) .0.99 0.143
Hyperkalemia (.6 meq/L), n/N (%) 0/10 0/158 1/6 (16.7) .0.99 0.375
*WBC=white cell count; APTT=activated partial thromboplastin time; PT=prothrombin time; ALT=serum alanine aminotransferase; AST=serum aspartate
aminotransferase; n/N=no. of patients/no. of patients with data available.
{Data detected from specimen(s) sampled at patient’s arrival at the hospital.
{Pre-fatal laboratory data were data detected from the blood specimens of fatal patients sampled within the immediate 48 h before fatality.
1Bandemia referred to presence of band cell (immature white blood cell) in peripheral blood.
"Prolongation of PT was defined as a PT.3 seconds than that of control.
**Prolongation of APTT was defined an APTT.20% than that of control.
doi:10.1371/journal.pntd.0001532.t002
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laboratory features between the fatal patients and
controls, and comparisons of the pre-fatal and initial
laboratory features of the fatal patients
Significant differences in demographics and clinical manifesta-
tions between fatal patients and controls included male gender
(80% vs. 44.1%, P=0.047), hypovolemic shock due to massive GI
bleeding (50% vs. 0.7%, P,0.001), concurrent bacteremia (37.5%
vs. 3.9%. P=0.010), concurrent bacteremia with shock (25% vs.
1.3%, P=0.022), DSS (40% vs. 2.3%, P,0.001), pulmonary
edema (30% vs. 2.8%; P=0.005), acute renal failure (100% vs.
2%; P,0.001), acute hepatic failure (57.1% vs. 4.4%; P,0.001),
hypothermia (20% vs. 0%, P=0.001), GI bleeding (90% vs. 16%,
P,0.001), massive GI bleeding (50% vs. 0.7%; P,0.001),
subarachnoid hemorrhage (10% vs. 0%, P=0.032) and early
altered consciousness (40% vs. 0%, P,0.001) (Table 1).
Significant higher proportion of bandemia (37.5% vs. 1.8%;
P=0.001) from initial laboratory data between the fatal patients
and the controls, and significant higher proportion of pre-fatal
leukocytosis (66.7% vs. 10%; P=0.020) and lower pre-fatal
platelet count (median, 17000 cells/mL vs. 35000 cells/mL;
P,0.001) as compared to the initial laboratory data of the fatal
patients were found (Table 2).
Discussion
The time interval from the dengue onset to patients’ arrival at
KSCGMH between the fatal and control groups did not differ
significantly (median, 2 days vs. 3 days; P=0.055) (Table 1). The
timing of admission in both the fatal and control groups allowed us
to evaluate the critical evolutionary changes in the dengue-affected
patients because critical events (e.g., dropped blood pressure and
circulation collapse) usually occur between day 3 and day 7 of the
disease course [17,18].
Dengue case fatality rate was reported to vary from 0.5% to
5.0% [2–4,7,9,10,12]. However, once DSS developed, the case
fatality may soar to as high as 12–44% [3–5]. Our series showed
that of all dengue-related deaths, DSS alone accounted for only
20%, while intractable massive GI bleeding alone for 40%, and
DSS with concurrent subarachnoid hemorrhage, intractable
massive GI bleeding with concurrent bacteremia, bacterial sepsis
with meningitis, and sepsis due to ventilator associated pneumonia
each were responsible for 10%.
DSS is characterized by severe plasma leak that leads to rapidly
developed shock, and timely volume replacement is the corner-
stone of therapy for the affected patients [17]. Notably, the
volumes of intravenous fluid supplement prior to the full blown
development of DSS in the 3 patients (patients 5, 8, 10) in our
series were obviously suboptimal [17,18]; in spite of the
subsequent fluid resuscitation and blood/blood component
transfusion, they died of profound shock and multi-organ failure
between day 6 and day 7 after the onset of illness. The pulmonary
edema developed in the 2 patients (patients 5 and 8) with DSS on
day 5 and day 6 after the dengue onset, respectively, was
accompanied by a concurrent marked hemoconcentration (see
Table S1 for details) suggested continuous fluid leakage from the
intravascular compartment to the extravascular compartment and
the lung alveolar space in particular, leading to profound shock
and pulmonary edema. In contrast, the pulmonary edema
developed on day 16 in patients 4 who had an underlying lung
cancer with malignant pleural effusion obviously resulted from
fluid overload.
The latest WHO scheme classified dengue in terms of clinical
severity as severe dengue (i.e., presence of severe bleeding, severe
plasma leak and/or severe organ involvement) or non-severe
dengue; for practical reasons, patients with non-severe dengue
were further separated into those with warning signs (i.e.,
abdominal pain, persistent vomiting, clinical fluid accumulation,
mucosal bleeding, lethargy/restless, liver enlargement, and
increase in hematocrit in concurrent with rapid decrease in
platelet count) and those without them [18]. Severe dengue
patients with aggravated plasma leak and/or bleeding necessitate
aggressive fluid resuscitation and additional blood transfusion as
necessary, while non-severe dengue patients with warning sign(s)
require strict observation, appropriate medical intervention and
intravenous hydration, as they are at high risk for evolving into
critical phase–severe dengue [18]. In addition to the aforemen-
tioned ones, our data suggest that leukocytosis, bandemia and
hypothermia may be warning signs of severe dengue. From the
pathophysiological point of view, leukocytosis and/or bandemia
indicates a superimposing bacterial infection and/or other stressful
stimuli [19]. Our data suggested that massive GI bleeding (33.3%)
and bacteremia (25%) be the major causes of DHF patients’ pre-
fatal leukocytosis. Significantly, leukocytosis was found in the
deceased patients before their death, and bandemia was found at
the fatal patients’ hospital presentation (Table 2); the latter suggest
that bandemia may be an early warning parameter of severe
dengue.
Mucosal bleeding may occur in any patient with dengue, and if
the patient remains stable with fluid resuscitation/replacement,
the mucosal bleeding should be considered a minor one [18].
Minor mucosal bleeding in dengue patients often results from
diapedesis of erythrocytes around blood vessels with little
inflammatory reaction [20]. If major bleeding occurs, it is usually
from the GI tract [2,12,21,22], and one of the risk factors for
major GI bleeding is the existence of a peptic ulcer [21], which is
unfortunately not uncommonly develops in patients under stress
[23]. One dengue series with 30 fatal dengue cases included
disclosed that 80% of the fatal patients experienced GI bleeding,
and severe bleeding with shock accounted for 30% of fatality [2].
The previously reported data [2,12,22] and ours suggest that even
minor or moderate GI bleeding should be regarded as a warning
sign of severe dengue and the patient in question needs close
monitoring, as it potentially evolved into life-threatening intrac-
table massive GI bleeding. Gastric ulcer and hemorrhagic gastritis
each endoscopically found in one fatal patient with massive GI
bleeding in our series raises the question of whether a H2-blocker
or proton-pump inhibitor should be used in patients with severe
DHF patients for prevention of massive GI bleeding. Further study
is needed to answer this question.
Of note, massive GI bleeding was found in 75% of patients who
experienced early altered consciousness (Table 1); 50% of patients
with pre-fatal PT prolongation and 33.3% of patients with pre-
fatal profound thrombocytopenia experienced massive GI bleed-
ing. These data suggested that clinicians be alert to the potential
development of severe GI bleeding when facing DHF patients with
altered consciousness, and persistent PT prolongation and
thrombocytopenia, and thereby initiate a timely management as
necessary.
Abdominal pain and persistent vomiting, the previously
reported clinical warning signs of severe dengue [11,17,18], did
not differ between the fatal patients and controls in this series. In
contrast, hypothermia significantly found in the fatal patients
suggested that it should be considered a warning sign of severe
dengue. Dengue-affected patients with hypothermia should
therefore be intensively monitored, and aggressive workup is
needed to clarify the potential cause(s) so that an effective
treatment can be started timely.
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altered consciousness suffered concurrent bacterial sepsis (K.
pneumoniae meningitis and E. faecalis bacteremia, respectively),
highlighting the need for an immediate empirical antibiotic
administration for dengue-affected patients with altered conscious-
ness for the presumably superimposing bacterial sepsis until it is
proven otherwise.
The bacteria (2 K. pneumoniae and 1 E. faecalis isolates) grew from
culture of blood of 3 patients (two of them each with the
underlying hypertension and lung cancer) sampled within 48 h
after their admission were of normal intestinal flora. Our
observation and previously reported concurrent bacteremia in
patients with DHF caused by the members of Enterobacteriaceae
[12,24] suggested that DHF patients are vulnerable to blood-
stream invasion by microbes from the intestinal tract where they
normally inhabit. These findings are consistent with the develop-
ment of portal of entry for bacteria in bowels by disintegration of
intestinal mucosal barriers in DHF patients reported previously
[25,26]. Of the fatal bacteremic patients in this series, one patient
with K. pneumoniae bacteremia and the other with simultaneous K.
pneumoniae bacteremia and meningitis clearly experienced septic
shock, while the shock in the patients who suffered massive GI
bleeding and concurrently E. faecalis bacteremia might result from
both hypovolemia and sepsis in view that E. faecalis has relatively
low clinical virulence [27]. Nevertheless, our data suggest that
when it comes to empirical use of antibiotic for suspicious
concurrent bacteremia in dengue-affected patients, it is reasonable
to cover bacteria from the intestinal tract.
It is not surprising that acute renal failure (100%) and acute
hepatic failure (57.1%) exclusively developed in fatal DHF patients
in our series, as severe plasma leakage, massive bleeding and/or
profound shock would lead to tissue hypo-perfusion, potentially
rendering acute renal failure and hepatic failure [16,28,29].
There are some limitations in the present study. First, the
fatalities in this series may be biased by patients’ severity resulting
from patient selection and referral pattern in a single medical
center. Second, the lack of a standardized treatment protocol for
severe dengue cases might bias patients’ clinical outcomes in this
retrospective analysis; this study thus addressed the pre-fatal
clinical and laboratory evolutions in the deceased DHF patients,
but not the appropriateness of treatment for them. Third, the
small number of fatal cases made the statistical power quite small.
In summary, our report highlights the causes of fatality other
than DSS in patients with severe dengue, and suggested that in
addition to those mentioned by the WHO 2009 scheme,
hypothermia, leukocytosis, and bandemia may be warning signs
of severe dengue. Early altered consciousness and GI bleeding/
massive GI bleeding were significantly found among deceased
DHF patients in this series. Dengue-affected patients should be
closely monitored and appropriately treated once GI bleeding
emerges, as it potentially evolved into massive GI bleeding; once
massive GI bleeding develops, patients are at high risk for
mortality, and this may be particularly true in patients with early
altered consciousness, leukocytosis, profound thrombocytopenia
and PT prolongation. Antibiotic(s) should be empirically added for
patients at risk for developing concurrent bacteremia, especially in
those with early altered consciousness and emergence of
leukocytosis. Our data suggest that bandemia at hospital
presentation may be a warning parameter for severe dengue,
and monitoring the potential emergence of leukocytosis and
persistence of thrombocytopenia may be helpful in evaluation of
the progressive dengue severity. Further study is needed to confirm
our observations. The findings of the suboptimal fluid resuscita-
tions and blood/blood component transfusions in some of the fatal
cases in this series underscores the importance of a timely effective
volume replacement by fluid infusion and blood/blood component
transfusion for patients with a severe dengue.
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